Compare Recursion Pharmaceuticals Inc (RXRX) vs Xpeng Inc - ADR (XPEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Xpeng Inc - ADR — how do they compare? Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B), while Xpeng Inc - ADR trades at $13.38 (market cap $12.96B). The key difference: Xpeng Inc - ADR is far larger — about 8.5× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| RXRX | XPEV | |
|---|---|---|
Market Cap | $1.53B | $12.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $6.79 | $28.07 |
52-Week Low | $2.84 | $12.09 |
Enterprise Value | $946.50M | $15.07B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Xpeng Inc - ADR
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →
